(September 12, 2022) – “Odgers Berndtson is delighted Peter Schineller has joined us as a Partner and Head of our US Life Sciences practice,” commented Steve Potter, CEO of Odgers Berndtson US. “Peter is joining us at a time of high growth for our Life Sciences practice. With more than 25 years of experience in the industry spanning the pharmaceutical, biotech and diagnostic segments, Peter has held C-suite leadership positions in virtually all the functional areas within Life Sciences companies. This experience, combined with his executive search experience, affords him the unique ability to understand all that is required to lead and recruit for high-performing, distinctive organizations.”
“I am thrilled to have joined Odgers Berndtson at a time of expansion across the Global Life Sciences practice” said Peter Schineller. “In addition to my significant executive search experiences, I bring with me a wealth of experience working within innovative, growing Life Sciences companies. Odgers Berndtson is nimble, entrepreneurial and its reach is truly global. I look forward to working with this great team to leverage my knowledge, expertise, and leadership background to better serve CEOs and C-Suite executives at Life Sciences companies seeking leading edge talent and human capital advisory services.
Prior to assuming his new role, Peter was a Managing Director with Diversified Search Group’s Life Science Practice. Before that he served as Managing Director of BioQuest, a retained executive search firm recruiting healthcare innovators.
Peter has significant commercial launch experience, having managed the pre- and post-launch of more than seven newly approved products, in addition to being responsible for the creation of numerous sales and marketing organizations. He has deep expertise operating in both large cap and early-stage companies, including the co-founding of a start-up that raised more than $150M in venture funding. He has also served in strategic and commercial roles for life sciences companies Depomed, Inc. where he reported directly to the CEO; SkylineDx BV; Agendia, Inc.; Alexza Pharmaceuticals; Ventana Medical Systems; Genoptix Medical Laboratory (a Novartis Company); Cypress Bioscience; Verus Pharmaceuticals; Elan Biopharmaceuticals; and Dura Pharaceuticals. Peter began his career with Abbott Laboratories, with rapid career progression culminating in his role as Director of Western U.S., Managed Health Care.
Peter is a graduate of the State University of New York at Stony Brook with a dual major in Political Science and History. He is also a former Commissioned Officer in the United States Marine Corps where he attained the rank of Captain. Peter will be based in Los Angeles.